CN101285060B - Process of chitosan-arginine resin anion immobilizing chymotrypsin - Google Patents
Process of chitosan-arginine resin anion immobilizing chymotrypsin Download PDFInfo
- Publication number
- CN101285060B CN101285060B CN2008100697937A CN200810069793A CN101285060B CN 101285060 B CN101285060 B CN 101285060B CN 2008100697937 A CN2008100697937 A CN 2008100697937A CN 200810069793 A CN200810069793 A CN 200810069793A CN 101285060 B CN101285060 B CN 101285060B
- Authority
- CN
- China
- Prior art keywords
- chitosan
- arginine
- chymotrypsin
- solution
- filter residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
一种壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶的方法,涉及壳聚糖衍生物固定化酶的方法。本发明以市售壳聚糖为原料,先制备交联壳聚糖树脂。再制备壳聚糖-精氨酸阴离子树脂,最后进行希夫反应固定化胰凝乳蛋白酶而得成品。本发明具有方法简单,操作简便,反应条件温和,生产成本低,固定化酶的稳定性高,酶活回收率高达89.95%,半衰期长,即75℃的半衰期长达18小时,4℃的半衰期长达56天,最适pH值仅为5.92。采用本发明制备出的产品,可广泛应用于医药、食品、轻工业等行业的各种水相及非水相的酶促反应。A method for immobilizing chymotrypsin with chitosan-arginine anion resin relates to a method for immobilizing enzyme with chitosan derivatives. The invention uses commercially available chitosan as a raw material, and firstly prepares a cross-linked chitosan resin. Then prepare chitosan-arginine anion resin, and finally carry out Schiff reaction to immobilize chymotrypsin to obtain the finished product. The invention has the advantages of simple method, convenient operation, mild reaction conditions, low production cost, high stability of immobilized enzyme, high enzyme activity recovery rate of 89.95%, and long half-life, that is, the half-life at 75°C is as long as 18 hours, and the half-life at 4°C Up to 56 days, the optimum pH value is only 5.92. The product prepared by the invention can be widely used in various aqueous phase and non-aqueous phase enzymatic reactions in industries such as medicine, food, and light industry.
Description
技术领域technical field
本发明属于酶固定化技术领域,特别涉及壳聚糖衍生物固定化酶的方法。The invention belongs to the technical field of enzyme immobilization, in particular to a method for immobilizing enzymes with chitosan derivatives.
技术背景technical background
研究表明:胰凝乳蛋白酶在医药上具有消化脓汁和坏死组织,消净创面,局部消炎,促进血肿吸收,创面愈合等功效;在食品、轻工等行业具有分解蛋白质、皮革脱毛等功能。目前,使用的游离酶,主要有成本高,利用率低,排放的废酶还污染环境等缺点。因此,研制使用半衰期较长的新型固定化胰凝乳蛋白酶,具有重要的经济、社会价值。Studies have shown that: chymotrypsin has the functions of digesting pus and necrotic tissue, eliminating wounds, local anti-inflammation, promoting hematoma absorption, and wound healing in medicine; it has the functions of decomposing protein and depilating leather in food and light industries. At present, the free enzymes used mainly have the disadvantages of high cost, low utilization rate, and the discharged waste enzymes pollute the environment. Therefore, the development and use of a new type of immobilized chymotrypsin with a longer half-life has important economic and social value.
壳聚糖是自然界含量丰富、价廉易得的天然高分子材料,因其具有良好的成膜、保湿、吸附、抗菌等特性,广泛用于医药、食品、轻工等行业中。又因壳聚糖具有易生物降解,安全无毒,生物相容性好,容易进行化学修饰,特别是壳聚糖衍生物具有亲水性好、刚性大、机械性良好等特点,是优异的固定化酶的载体。Chitosan is a natural polymer material that is abundant in nature and cheap and easy to obtain. Because of its good film-forming, moisturizing, adsorption, and antibacterial properties, it is widely used in medicine, food, light industry and other industries. And because chitosan is easy to biodegrade, safe and non-toxic, has good biocompatibility, and is easy to carry out chemical modification, especially chitosan derivatives have the characteristics of good hydrophilicity, high rigidity, and good mechanical properties, which are excellent. Carriers for immobilized enzymes.
现有固定化酶的方法包括包埋法、吸附法、共价结合法及交联法等。包埋法是指将酶包埋在高分子凝胶细微网格或半透膜中,其制备工艺简便且反应条件较为温和,可获得较高的酶活力回收,由于只有小分子可通过高分子凝胶网格,且扩散阻力会导致酶活力降低,因此包埋法只适合作用于小分子底物和产物的酶。吸附法则是指酶被吸附于不溶性载体的固定化方法,该法操作简便,条件温和,酶的活力损失很少,载体价廉易得,可反复使用,但是,酶与载体的相互作用力弱,易脱落。共价结合法是指酶与载体以共价键结合的固定化方法,该法固定化的酶,不易脱落,可连续使用相当长的时间,但载体的活化比较复杂,且结合法有较激烈的反应而使酶活力损失较大。交联法指用双功能或多功能试剂使酶与载体之间交联的固定化方法,交联法固定化酶稳定性好,如宁波大学学报1999年3月第1期的“壳聚糖固定化胰蛋白酶的制备及理化性质研究”一文,公开了从甲克质粗品中获得的壳聚糖,再在交联剂戊二醛的作用下将胰蛋白酶固定到该壳聚糖上的方法;该法的不足之处在于从甲克质粗品中难以获得纯净的壳聚糖,而且直接以壳聚糖作为载体,胰蛋白酶大分子靠近时位阻大,直接交联固定化酶效率低,容易引起胰蛋白酶分子自交联。又如公开号CN1904043A的“一种纳米磁性壳聚糖固定化酶的制备方法”专利,公开了使用表面含有酰氯基团的纳米磁性壳聚糖与酶蛋白分子在磁场作用下反应制备固定化酶的方法;该法的不足之处在于制备一定粒径的纳米磁性壳聚糖载体比较困难,同时纳米磁性壳聚糖在使用过程中容易被氧化而发生沉聚,导致酶活力的降低。Existing methods for immobilizing enzymes include embedding, adsorption, covalent binding and cross-linking. The embedding method refers to embedding enzymes in polymer gel fine grids or semi-permeable membranes. The preparation process is simple and the reaction conditions are relatively mild, and high enzyme activity recovery can be obtained, because only small molecules can pass through polymers. Gel grid, and diffusion resistance will lead to reduced enzyme activity, so the embedding method is only suitable for enzymes that act on small molecule substrates and products. The adsorption method refers to the immobilization method in which the enzyme is adsorbed on an insoluble carrier. This method is easy to operate, with mild conditions, little loss of enzyme activity, and the carrier is cheap and easy to obtain, and can be used repeatedly. However, the interaction between the enzyme and the carrier is weak. , easy to fall off. The covalent binding method refers to the immobilization method in which the enzyme and the carrier are covalently bonded. The immobilized enzyme is not easy to fall off and can be used continuously for a long time, but the activation of the carrier is more complicated, and the binding method is more intense. The reaction caused a large loss of enzyme activity. The cross-linking method refers to the immobilization method of cross-linking between the enzyme and the carrier with a bifunctional or multifunctional reagent. The cross-linking method has good stability of the immobilized enzyme, such as "Chitosan" published in the first issue of the Journal of Ningbo University in March 1999. Preparation of immobilized trypsin and research on its physical and chemical properties” discloses the method of immobilizing trypsin on the chitosan obtained from chitosan crude product under the action of cross-linking agent glutaraldehyde The disadvantage of this method is that it is difficult to obtain pure chitosan from the crude product of chitosan, and chitosan is directly used as a carrier. When the macromolecule of trypsin is close to it, the steric hindrance is large, and the efficiency of direct crosslinking and immobilization of the enzyme is low. It is easy to cause self-crosslinking of trypsin molecules. Another example is the "Preparation Method of Nanomagnetic Chitosan Immobilized Enzyme" patent with publication number CN1904043A, which discloses the use of nanomagnetic chitosan containing acid chloride groups on the surface to react with enzyme protein molecules under the action of a magnetic field to prepare immobilized enzymes. method; the disadvantage of this method is that it is difficult to prepare a nano-magnetic chitosan carrier with a certain particle size, and at the same time, the nano-magnetic chitosan is easily oxidized and precipitated during use, resulting in a decrease in enzyme activity.
发明内容Contents of the invention
本发明的目的是针对现有壳聚糖树脂固定化酶方法的不足之处,提供一种壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶的方法。该方法具有操作简单、酶活回收率高、反应条件温和、制备成本低等特点,同时固定化胰凝乳蛋白酶较游离胰凝乳蛋白酶酶热稳定性增加,适用pH值降低,半衰期延长,而且可反复利用,减少污染,充分利用资源。The purpose of the present invention is to provide a method for immobilizing chymotrypsin with chitosan-arginine anion resin aiming at the shortcomings of the existing chitosan resin immobilization enzyme method. The method has the characteristics of simple operation, high recovery rate of enzyme activity, mild reaction conditions, and low preparation cost. At the same time, compared with free chymotrypsin, the thermal stability of immobilized chymotrypsin is increased, the applicable pH value is lowered, and the half-life is extended. It can be used repeatedly, reducing pollution and making full use of resources.
本发明的机理:由于壳聚糖分子链中含有大量的游离氨基,这些氨基有一孤对电子,具有很强的亲核性,而戊二醛是一种常用的双官能团试剂,可与壳聚糖的氨基发生交联反应生成席夫碱结构,交联主要是在分子间发生;二环己基碳二亚胺(DCC)是一种常用的接肽缩合剂,它可以活化羧基,即加强羧基碳原子的亲电性,使得亲核的非离子化氨基很容易对它进行攻击,从而发生缩合反应生成肽键。再次以戊二醛作为交联剂,使胰凝乳蛋白酶表面游离氨基与精氨酸残余氨基发生shiff反应,即得壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶。Mechanism of the present invention: because chitosan molecular chain contains a large amount of free amino groups, these amino groups have a lone pair of electrons, have very strong nucleophilicity, and glutaraldehyde is a kind of bifunctional reagent commonly used, can combine with chitosan The amino group of the sugar undergoes a cross-linking reaction to form a Schiff base structure, and the cross-linking mainly occurs between molecules; dicyclohexylcarbodiimide (DCC) is a commonly used peptide condensation agent, which can activate the carboxyl group, that is, strengthen the The electrophilicity of the carbon atom makes it easy for the nucleophilic non-ionized amino group to attack it, resulting in a condensation reaction to form a peptide bond. Using glutaraldehyde as a cross-linking agent again, the free amino groups on the surface of chymotrypsin and the residual amino groups of arginine undergo a shiff reaction to obtain chitosan-arginine anion resin immobilized chymotrypsin.
本发明的目的是这样实现的:一种壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶的方法,以市售壳聚糖为原料,先制备交联壳聚糖微球,再制备壳聚糖-精氨酸阴离子树脂,最后进行希夫反应固定化胰凝乳蛋白酶而得成品。具体的方法步骤如下:The object of the present invention is achieved like this: a kind of method for chitosan-arginine anion resin immobilization chymotrypsin, take commercially available chitosan as raw material, first prepare cross-linked chitosan microsphere, then prepare The chitosan-arginine anion resin is finally subjected to Schiff reaction to immobilize chymotrypsin to obtain the finished product. The specific method steps are as follows:
(1)制备交联壳聚糖树脂(1) Preparation of cross-linked chitosan resin
以市售壳聚糖为原料,先将壳聚糖加入盐酸质量百分数为1~5%稀盐酸中,搅拌溶解后,就制备出壳聚糖质量百分数为1~4%的壳聚糖酸性溶胶。后按壳聚糖酸性溶胶∶液体石蜡的体积比为1∶1~4的比例,将壳聚糖酸性溶胶缓慢加入液体石蜡中,搅拌20~30min,并加热升温至35~45℃制得到壳聚糖石蜡溶液后,再加入占壳聚糖石蜡溶液体积分数为0.05~0.25%的吐温80,进行乳化20~30min,然后加入占壳聚糖石蜡溶液体积分数为0.05~0.3%戊二醛交联剂,使壳聚糖分子的部分氨基参与交联反应,从而使线性壳聚糖分子转变成壳聚糖微球。再加入占壳聚糖石蜡溶液质量分数为0.01~0.1%碳酸钙致孔剂,进行制孔反应50~70min制得壳聚糖微球的悬浮液。最后用氢氧化钠溶液调节壳聚糖微球悬浮液的pH值为9~10,并加热至55~75℃,搅拌固化2~4h,再过滤,弃滤液,收集滤渣。对滤渣先用乙醇洗涤3~6次,后用质量分数为1~5%稀盐酸溶解滤渣中的碳酸钙,再用蒸馏水洗涤至中性,就制备出交联壳聚糖树脂。Using commercially available chitosan as a raw material, first add chitosan to dilute hydrochloric acid with a mass percentage of 1-5% hydrochloric acid, stir and dissolve, and prepare a chitosan acid sol with a mass percentage of chitosan of 1-4% . Finally, according to the ratio of chitosan acidic sol: liquid paraffin volume ratio of 1: 1 ~ 4, slowly add chitosan acidic sol into liquid paraffin, stir for 20 ~ 30min, and heat up to 35 ~ 45 ° C to obtain the shell After the polycan paraffin solution, add Tween 80 which accounts for 0.05-0.25% of the volume fraction of the chitosan paraffin solution, emulsifies for 20-30 minutes, and then adds 0.05-0.3% glutaraldehyde which accounts for the volume fraction of the chitosan paraffin solution. The cross-linking agent makes some of the amino groups of chitosan molecules participate in the cross-linking reaction, so that the linear chitosan molecules are transformed into chitosan microspheres. Then add 0.01-0.1% calcium carbonate porogen in the mass fraction of the chitosan paraffin wax solution, and carry out pore-forming reaction for 50-70 minutes to prepare a suspension of chitosan microspheres. Finally, adjust the pH value of the chitosan microsphere suspension to 9-10 with sodium hydroxide solution, heat to 55-75° C., stir and solidify for 2-4 hours, then filter, discard the filtrate, and collect the filter residue. The filter residue is washed with ethanol for 3 to 6 times, and then the calcium carbonate in the filter residue is dissolved with dilute hydrochloric acid with a mass fraction of 1 to 5%, and then washed with distilled water until neutral to prepare a cross-linked chitosan resin.
(2)壳聚糖-精氨酸阴离子树脂的制备(2) Preparation of chitosan-arginine anion resin
第(1)步完成后,将第(1)步制备出的交联壳聚糖树脂,加入精氨酸质量分数为0.5~2.0%精氨酸溶液中,振荡20~30min,使壳聚糖树脂悬浮于精氨酸溶液中,制备出壳聚糖质量分数为0.5~2.5%的壳聚糖-精氨酸溶液。然后按壳聚糖-精氨酸溶液中的精氨酸∶二环己基碳二亚胺(DCC)的摩尔比为1∶0.5~2.5的比例,在壳聚糖-精氨酸溶液中,加入DCC接肽缩合剂,进行缩合反应20~40min,使壳聚糖树脂中另一部分氨基与精氨酸的羧基发生缩合反应,就制备出壳聚糖-精氨酸树脂。最后经过滤,弃滤液,收集滤渣。对滤渣先用乙醇洗涤3~6次,后用蒸馏水透析8~12h后,再过滤,再弃滤液,再收集滤渣,就制备出壳聚糖-精氨酸阴离树脂。After the first step (1) is completed, the cross-linked chitosan resin prepared by the first step is added to the arginine solution with a mass fraction of 0.5 to 2.0% arginine and shaken for 20 to 30 minutes to make the chitosan The resin is suspended in the arginine solution, and the chitosan-arginine solution with the chitosan mass fraction of 0.5-2.5% is prepared. Then by the arginine in the chitosan-arginine solution: the mol ratio of dicyclohexylcarbodiimide (DCC) is the ratio of 1: 0.5~2.5, in the chitosan-arginine solution, add DCC is connected with a peptide condensing agent, and the condensation reaction is carried out for 20 to 40 minutes, so that another part of the amino group in the chitosan resin and the carboxyl group of arginine undergo a condensation reaction, and the chitosan-arginine resin is prepared. Finally, after filtration, discard the filtrate and collect the filter residue. Wash the filter residue with ethanol for 3 to 6 times, then dialyze with distilled water for 8 to 12 hours, then filter, discard the filtrate, and collect the filter residue to prepare the chitosan-arginine anion resin.
(3)胰凝乳蛋白酶的固定(3) Immobilization of chymotrypsin
第(2)步完成后,先将胰凝乳蛋白酶加入pH值为4.5~6.0磷酸盐缓冲液中,搅拌均匀,就制备出胰凝乳蛋白酶的摩尔浓度为0.05~0.08mol/L的胰凝乳蛋白酶磷酸盐溶液。后按第(2)步制备出的壳聚糖-精氨酸阴离子树脂∶胰凝乳蛋白酶磷酸盐溶液中胰凝乳蛋白酶的质量比为1∶15~25的比例,将壳聚糖-精氨酸阴离子树脂加入胰凝乳蛋白酶磷酸盐溶液中,在30~60℃的恒温水浴条件下,振荡20~40min,使壳聚糖-精氨酸阴离子树脂悬浮于胰凝乳蛋白酶磷酸盐溶液中。再按戊二醛∶壳聚糖-精氨酸阴离子树脂的质量比为1∶6~14的比例,将戊二醛加入到悬浮壳聚糖-精氨酸阴离子树脂的胰凝乳蛋白酶磷酸盐溶液中,并置于振荡器中振荡,进行希夫反应50~70min后,进行抽滤,弃滤液,收集树脂滤渣,对树脂滤渣用磷酸盐缓冲液洗涤4~7次,除去游离胰凝乳蛋白酶,再抽滤,再弃滤液,再收集壳聚糖-精氨酸阴离子固定化胰凝乳蛋白酶滤渣而得成品。After step (2) is completed, first add chymotrypsin into the phosphate buffer solution with a pH value of 4.5 to 6.0, and stir evenly to prepare chymotrypsin with a molar concentration of 0.05 to 0.08mol/L. Lactase Phosphate Solution. Chitosan-arginine anion resin prepared by the step (2): the mass ratio of chymotrypsin in the chymotrypsin phosphate solution is the ratio of 1: 15~25, the chitosan-arginine Add arginine anion resin to the chymotrypsin phosphate solution, shake for 20 to 40 minutes in a constant temperature water bath at 30-60°C, and suspend the chitosan-arginine anion resin in the chymotrypsin phosphate solution . Then by glutaraldehyde: the mass ratio of chitosan-arginine anion resin is the ratio of 1: 6~14, glutaraldehyde is added to the chymotrypsin phosphate of suspension chitosan-arginine anion resin solution, and placed in an oscillator to vibrate, carry out Schiff reaction for 50 to 70 minutes, carry out suction filtration, discard the filtrate, collect the resin filter residue, wash the resin filter residue with phosphate buffer saline for 4 to 7 times, and remove free pancreatin The protease is then suction filtered, and the filtrate is discarded, and the chitosan-arginine anion immobilized chymotrypsin filter residue is collected to obtain the finished product.
本发明采用上述技术方案后,主要有以下特点:After the present invention adopts the above-mentioned technical scheme, it mainly has the following characteristics:
(1)固定化效果好。由于精氨酸分子中胍基和羧基之间具有一个长脂肪链结构-(CH2)4,当壳聚糖树脂与精氨酸反应后,相当于给壳聚糖树脂接上许多“悬臂”,以其作为固定化酶的载体,避免了酶蛋白大分子靠近载体时位阻大,直接交联固定化酶效率低,且易引起酶分子自交联等缺点,所以固定化酶效果更好;以该固定化酶进行酶促反应,更利于固定化酶与反应介质接触,提高反应效率。(1) The immobilization effect is good. Since there is a long aliphatic chain structure-(CH 2 ) 4 between the guanidinium group and the carboxyl group in the arginine molecule, when the chitosan resin reacts with arginine, it is equivalent to connecting many "cantilevers" to the chitosan resin , using it as a carrier for immobilized enzymes avoids the disadvantages of high steric hindrance when the enzyme protein macromolecule is close to the carrier, low efficiency of direct cross-linking immobilized enzymes, and easy to cause self-crosslinking of enzyme molecules, so the effect of immobilized enzymes is better ; Carrying out the enzymatic reaction with the immobilized enzyme is more conducive to the contact between the immobilized enzyme and the reaction medium, and improves the reaction efficiency.
(2)固定化酶的稳定性高。本发明方法是采用戊二醛交联法固定胰凝乳蛋白酶,增加酶与载体之间的结合力,提高固定化酶的机械强度,避免使用过程中酶分子从载体上脱落的缺陷,使得酶的稳定性得到了进一步的增强。(2) The stability of the immobilized enzyme is high. The method of the present invention adopts the glutaraldehyde cross-linking method to fix chymotrypsin, increases the binding force between the enzyme and the carrier, improves the mechanical strength of the immobilized enzyme, and avoids the defect that the enzyme molecule falls off from the carrier during use, so that the enzyme The stability has been further enhanced.
(3)适用pH值降低。游离胰凝乳蛋白酶的最适pH值为8.0,而固定化胰凝乳蛋白酶的最适pH值仅为5.92,进一步扩大了胰凝乳蛋白酶的使用范围。(3) The applicable pH value is lowered. The optimum pH value of free chymotrypsin is 8.0, while that of immobilized chymotrypsin is only 5.92, which further expands the scope of use of chymotrypsin.
(4)生产成本低。本发明方法采用壳聚糖-精氨酸阴离子树脂固定化的胰凝乳蛋白酶更容易与有机溶剂分离,更有利于酶的回收利用,提高酶的使用效率,降低生产成本。(4) Low production cost. The method of the invention adopts the chitosan-arginine anion resin immobilized chymotrypsin to be more easily separated from the organic solvent, is more conducive to the recovery and utilization of the enzyme, improves the use efficiency of the enzyme, and reduces the production cost.
(5)酶活回收率高、半衰期长。固定化的胰凝乳蛋白酶热稳定性增加,酶活回收率高达89.95%。半衰期延长,即75℃半衰期长达18小时,4℃半衰期长达56天。(5) The recovery rate of enzyme activity is high and the half-life is long. The thermal stability of the immobilized chymotrypsin is increased, and the recovery rate of the enzyme activity is as high as 89.95%. The half-life is extended, that is, the half-life at 75°C is as long as 18 hours, and the half-life at 4°C is as long as 56 days.
(6)本发明方法简单,操作简便,生产过程中反应条件温和,便于推广应用。(6) The method of the present invention is simple, easy to operate, and the reaction conditions are mild in the production process, which is convenient for popularization and application.
采用本发明方法制备出的壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶,可广法应用于医药、食品、轻工等行业的各种水相及非水相的酶促反应。The chitosan-arginine anion resin immobilized chymotrypsin prepared by the method of the invention can be widely used in various water phase and non-aqueous phase enzymatic reactions in medicine, food, light industry and other industries.
具体实施方式Detailed ways
下面结合具体实施方式,进一步说明本发明。The present invention will be further described below in combination with specific embodiments.
实施例一Embodiment one
一种壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶的方法的具体步骤如下:A kind of concrete steps of the method for chitosan-arginine anion resin immobilization chymotrypsin are as follows:
(1)制备交联壳聚糖树脂(1) Preparation of cross-linked chitosan resin
以市售壳聚糖为原料,先将壳聚糖加入盐酸质量百分数为2%稀盐酸中,搅拌溶解后,就制备出壳聚糖质量百分数为2%的壳聚糖酸性溶胶。后按壳聚糖酸性溶胶∶液体石蜡的体积比为1∶1的比例,将壳聚糖酸性溶胶缓慢加入液体石蜡中,搅拌25min,并加热升温至40℃制得到壳聚糖石蜡溶液后,再加入占壳聚糖石蜡溶液体积分数为0.1%的吐温80,进行乳化25min,然后加入占壳聚糖石蜡溶液体积分数为0.15%戊二醛交联剂,使壳聚糖分子的部分氨基参与交联反应,从而使线性壳聚糖分子转变成壳聚糖微球。再加入占壳聚糖石蜡溶液质量分数为0.05%碳酸钙致孔剂,进行制孔反应60min制得壳聚糖微球的悬浮液。最后用氢氧化钠溶液调节壳聚糖微球悬浮液的pH值为9.5,并加热至60℃,搅拌固化3h,再过滤,弃滤液,收集滤渣。对滤渣先用乙醇洗涤5次,后用质量分数为3%稀盐酸溶解滤渣中的碳酸钙,再用蒸馏水洗涤至中性,就制备出交联壳聚糖树脂。Using commercially available chitosan as a raw material, the chitosan is firstly added into dilute hydrochloric acid with a mass percentage of 2% hydrochloric acid, stirred and dissolved, and a chitosan acid sol with a mass percentage of chitosan of 2% is prepared. Afterwards, the volume ratio of chitosan acid sol: liquid paraffin is 1: 1, chitosan acid sol is slowly added in liquid paraffin, stirred for 25min, and heated to 40°C to obtain the chitosan paraffin solution, Adding and accounting for chitosan paraffin solution volume fraction is 0.1% Tween 80 again, carry out emulsification 25min, then add and account for chitosan paraffin solution volume fraction and be 0.15% glutaraldehyde cross-linking agent, make the part amino group of chitosan molecule Participate in the cross-linking reaction, thereby converting linear chitosan molecules into chitosan microspheres. Then add 0.05% calcium carbonate pore-forming agent accounting for the mass fraction of the chitosan paraffin solution, and carry out pore-forming reaction for 60 minutes to prepare a suspension of chitosan microspheres. Finally, adjust the pH value of the chitosan microsphere suspension to 9.5 with sodium hydroxide solution, heat to 60° C., stir and solidify for 3 hours, then filter, discard the filtrate, and collect the filter residue. The filter residue was first washed with ethanol for 5 times, and then the calcium carbonate in the filter residue was dissolved with 3% dilute hydrochloric acid, and then washed with distilled water until neutral to prepare a cross-linked chitosan resin.
(2)壳聚糖-精氨酸阴离子树脂的制备(2) Preparation of chitosan-arginine anion resin
第(1)步完成后,将第(1)步制备出的交联壳聚糖树脂,加入精氨酸质量分数为1%精氨酸溶液中,振荡25min,使壳聚糖树脂悬浮于精氨酸溶液中,制备出壳聚糖质量分数为1.5%的壳聚糖-精氨酸溶液。然后按壳聚糖-精氨酸溶液中的精氨酸∶二环己基碳二亚胺(DCC)的摩尔比为1∶1的比例,在壳聚糖-精氨酸溶液中,加入DCC接肽缩合剂,进行缩合反应30min,使壳聚糖树脂中另一部分氨基与精氨酸的羧基发生缩合反应,就制备出壳聚糖-精氨酸树脂。最后经过滤,弃滤液,收集滤渣。对滤渣先用乙醇洗涤4次,后用蒸馏水透析10h后,再过滤,再弃滤液,再收集滤渣,就制备出壳聚糖-精氨酸阴离树脂。After the first (1) step was completed, the cross-linked chitosan resin prepared by the (1) step was added to the arginine mass fraction of 1% arginine solution, and vibrated for 25 minutes to suspend the chitosan resin in the arginine solution. A chitosan-arginine solution with a chitosan mass fraction of 1.5% was prepared. Then by the arginine in the chitosan-arginine solution: the mol ratio of dicyclohexylcarbodiimide (DCC) is the ratio of 1: 1, in the chitosan-arginine solution, add DCC to connect Peptide condensing agent, carry out condensation reaction 30min, make another part of amino group in chitosan resin and the carboxyl group of arginine produce condensation reaction, just prepare chitosan-arginine resin. Finally, after filtration, discard the filtrate and collect the filter residue. The filter residue was first washed with ethanol for 4 times, then dialyzed with distilled water for 10 hours, filtered again, the filtrate was discarded, and the filter residue was collected to prepare the chitosan-arginine anion resin.
(3)胰凝乳蛋白酶的固定(3) Immobilization of chymotrypsin
第(2)步完成后,先将胰凝乳蛋白酶加入pH值为5.9磷酸盐缓冲液中,搅拌均匀,就制备出胰凝乳蛋白酶的摩尔浓度为0.06mol/L的胰凝乳蛋白酶磷酸盐溶液。后按第(2)步制备出的壳聚糖-精氨酸阴离子树脂∶胰凝乳蛋白酶磷酸盐溶液中胰凝乳蛋白酶的质量比为1∶20的比例,将壳聚糖-精氨酸阴离子树脂加入胰凝乳蛋白酶磷酸盐溶液中,在45℃的恒温水浴条件下,振荡30min,使壳聚糖-精氨酸阴离子树脂悬浮于胰凝乳蛋白酶磷酸盐溶液中。再按戊二醛∶壳聚糖-精氨酸阴离子树脂的质量比为1∶8的比例,将戊二醛加入到悬浮壳聚糖-精氨酸阴离子树脂的胰凝乳蛋白酶磷酸盐溶液中,并置于振荡器中振荡,进行希夫反应60min后,进行抽滤,弃滤液,收集树脂滤渣,对树脂滤渣用磷酸盐缓冲液洗涤6次,除去游离胰凝乳蛋白酶,再抽滤,再弃滤液,再收集壳聚糖-精氨酸阴离子固定化胰凝乳蛋白酶滤渣而得成品。After step (2) is completed, first add chymotrypsin to the phosphate buffer with a pH value of 5.9, stir evenly, and then prepare chymotrypsin phosphate with a molar concentration of chymotrypsin of 0.06mol/L solution. Chitosan-arginine anion resin prepared by the step (2): the mass ratio of chymotrypsin in the chymotrypsin phosphate solution is the ratio of 1: 20, the chitosan-arginine Add the anion resin to the chymotrypsin phosphate solution, shake for 30 minutes under the condition of a constant temperature water bath at 45° C., and suspend the chitosan-arginine anion resin in the chymotrypsin phosphate solution. Then by glutaraldehyde: the mass ratio of chitosan-arginine anion resin is the ratio of 1: 8, glutaraldehyde is added in the chymotrypsin phosphate solution of suspended chitosan-arginine anion resin , and placed in an oscillator to oscillate, carry out Schiff reaction for 60min, carry out suction filtration, discard the filtrate, collect the resin filter residue, wash the resin filter residue 6 times with phosphate buffer saline, remove free chymotrypsin, and then suction filter, Then discard the filtrate, and then collect chitosan-arginine anion-immobilized chymotrypsin filter residue to obtain the finished product.
实施例二Embodiment two
一种壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶的方法的具体步骤如下:A kind of concrete steps of the method for chitosan-arginine anion resin immobilization chymotrypsin are as follows:
(1)制备交联壳聚糖树脂(1) Preparation of cross-linked chitosan resin
同实施例一,特征是:将壳聚糖加入盐酸质量百分数为1%稀盐酸中,制备出壳聚糖质量百分数为1%的壳聚糖酸性溶胶。壳聚糖酸性溶胶∶液体石蜡的体积比为1∶2,搅拌20min,并加热升温至35℃,再加入占壳聚糖石蜡溶液体积分数为0.05%的吐温80,进行乳化20min,然后加入占壳聚糖石蜡溶液体积分数为0.05%戊二醛交联剂,再加入占壳聚糖石蜡溶液质量分数为0.01%碳酸钙致孔剂,进行制孔反应50min。用氢氧化钠溶液调节壳聚糖微球悬浮液的pH值为9,并加热至55℃,搅拌固化2h,对滤渣先用乙醇洗涤3次,后用质量分数为1%稀盐酸溶解滤渣中的碳酸钙。Same as Example 1, the feature is that chitosan is added into dilute hydrochloric acid with a mass percentage of 1% hydrochloric acid to prepare a chitosan acidic sol with a mass percentage of chitosan. Chitosan acidic sol: the volume ratio of liquid paraffin is 1: 2, stir for 20min, and heat up to 35°C, then add Tween 80 accounting for 0.05% of the chitosan paraffin solution volume fraction, emulsify for 20min, and then add The volume fraction of the chitosan paraffin solution is 0.05% glutaraldehyde crosslinking agent, and then the chitosan paraffin solution mass fraction is 0.01% calcium carbonate porogen, and the pore-forming reaction is carried out for 50 minutes. Use sodium hydroxide solution to adjust the pH value of the chitosan microsphere suspension to 9, heat to 55 ° C, stir and solidify for 2 hours, wash the filter residue with ethanol for 3 times, and then dissolve the filter residue with 1% dilute hydrochloric acid. of calcium carbonate.
(2)壳聚糖-精氨酸阴离子树脂的制备(2) Preparation of chitosan-arginine anion resin
同实施例一,特征是:精氨酸溶液中精氨酸质量分数为0.5%,振荡20min,制备出壳聚糖质量分数为0.5%的壳聚糖-精氨酸溶液。壳聚糖-精氨酸溶液中精氨酸∶二环己基碳二亚胺(DCC)的摩尔比为1∶0.5,进行缩合反应20min,对滤渣先用乙醇洗涤3次,后用蒸馏水透析8h。Same as Example 1, the feature is: the mass fraction of arginine in the arginine solution is 0.5%, shake for 20 minutes, and prepare a chitosan-arginine solution with a mass fraction of chitosan of 0.5%. The molar ratio of arginine: dicyclohexylcarbodiimide (DCC) in the chitosan-arginine solution is 1:0.5, carry out the condensation reaction for 20 minutes, wash the filter residue with ethanol for 3 times, and then dialyze with distilled water for 8 hours .
(3)胰凝乳蛋白酶的固定(3) Immobilization of chymotrypsin
同实施例一,特征是:先将胰凝乳蛋白酶加入pH值为4.5磷酸盐缓冲液中,制备出胰凝乳蛋白酶的摩尔浓度为0.05mol/L的胰凝乳蛋白酶磷酸盐溶液。第(2)步制备出的壳聚糖-精氨酸阴离子树脂∶胰凝乳蛋白酶磷酸盐溶液中胰凝乳蛋白酶的质量比为1∶15,在30℃的恒温水浴条件下,振荡20min,戊二醛∶壳聚糖-精氨酸阴离子树脂的质量比为1∶6,进行希夫反应50min,对树脂滤渣用磷酸盐缓冲液洗涤4次。Same as Example 1, the feature is: firstly add chymotrypsin into the phosphate buffer with a pH value of 4.5 to prepare a chymotrypsin phosphate solution with a molar concentration of chymotrypsin of 0.05 mol/L. Chitosan-arginine anion resin prepared in (2): the mass ratio of chymotrypsin in the chymotrypsin phosphate solution is 1: 15, under the constant temperature water bath condition of 30 ℃, shake 20min, The mass ratio of glutaraldehyde: chitosan-arginine anion resin was 1:6, Schiff reaction was carried out for 50 min, and the resin filter residue was washed 4 times with phosphate buffer saline.
实施例三Embodiment Three
一种壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶的方法的具体步骤如下:A kind of concrete steps of the method for chitosan-arginine anion resin immobilization chymotrypsin are as follows:
(1)制备交联壳聚糖树脂(1) Preparation of cross-linked chitosan resin
同实施例一,特征是:将壳聚糖加入盐酸质量百分数为5%稀盐酸中,制备出壳聚糖质量百分数为4%的壳聚糖酸性溶胶。壳聚糖酸性溶胶∶液体石蜡的体积比为1∶4,搅拌30min,并加热升温至45℃,再加入占壳聚糖石蜡溶液体积分数为0.25%的吐温80,进行乳化30min,然后加入占壳聚糖石蜡溶液体积分数为0.3%戊二醛交联剂,再加入占壳聚糖石蜡溶液质量分数为0.1%碳酸钙致孔剂,进行制孔反应70min。用氢氧化钠溶液调节壳聚糖微球悬浮液的pH值为10,并加热至75℃,搅拌固化4h,对滤渣先用乙醇洗涤6次,后用质量分数为5%稀盐酸溶解滤渣中的碳酸钙。Same as Example 1, the feature is that chitosan is added into dilute hydrochloric acid with a mass percentage of 5% hydrochloric acid to prepare a chitosan acidic sol with a mass percentage of chitosan of 4%. Chitosan acidic sol: the volume ratio of liquid paraffin is 1: 4, stir for 30min, and heat up to 45°C, then add Tween 80 accounting for 0.25% of the chitosan paraffin solution volume fraction, emulsify for 30min, and then add The volume fraction of the chitosan paraffin solution is 0.3% glutaraldehyde crosslinking agent, and the mass fraction of the chitosan paraffin solution is 0.1% calcium carbonate porogen, and the pore-forming reaction is carried out for 70 minutes. Use sodium hydroxide solution to adjust the pH value of the chitosan microsphere suspension to 10, heat to 75°C, stir and solidify for 4 hours, wash the filter residue with ethanol for 6 times, and then dissolve the filter residue with 5% dilute hydrochloric acid. of calcium carbonate.
(2)壳聚糖-精氨酸阴离子树脂的制备(2) Preparation of chitosan-arginine anion resin
同实施例一,特征是:精氨酸溶液中精氨酸质量分数为2.0%,振荡30min,制备出壳聚糖质量分数为2.5%的壳聚糖-精氨酸溶液。壳聚糖-精氨酸溶液中精氨酸∶二环己基碳二亚胺(DCC)的摩尔比为1∶2.5,进行缩合反应40min,对滤渣先用乙醇洗涤6次,后用蒸馏水透析12h。Same as Example 1, the feature is: the mass fraction of arginine in the arginine solution is 2.0%, shake for 30 minutes, and prepare a chitosan-arginine solution with a mass fraction of chitosan of 2.5%. The molar ratio of arginine: dicyclohexylcarbodiimide (DCC) in the chitosan-arginine solution is 1: 2.5, carry out the condensation reaction for 40 minutes, wash the filter residue with ethanol for 6 times, and then dialyze with distilled water for 12 hours .
(3)胰凝乳蛋白酶的固定(3) Immobilization of chymotrypsin
同实施例一,特征是:先将胰凝乳蛋白酶加入pH值为6.0磷酸盐缓冲液中,制备出胰凝乳蛋白酶的摩尔浓度为0.08mol/L的胰凝乳蛋白酶磷酸盐溶液。第(2)步制备出的壳聚糖-精氨酸阴离子树脂∶胰凝乳蛋白酶磷酸盐溶液中胰凝乳蛋白酶的质量比为1∶25,在60℃的恒温水浴条件下,振荡40min,戊二醛∶壳聚糖-精氨酸阴离子树脂的质量比为1∶14的比例,进行希夫反应70min后,对树脂滤渣用磷酸盐缓冲液洗涤7次。Same as Example 1, the feature is: firstly add chymotrypsin into the phosphate buffer with a pH value of 6.0 to prepare a chymotrypsin phosphate solution with a molar concentration of chymotrypsin of 0.08 mol/L. The chitosan-arginine anion resin prepared in the 2nd step: the mass ratio of chymotrypsin in the chymotrypsin phosphate solution is 1: 25, under the constant temperature water bath condition of 60 ℃, shake 40min, The mass ratio of glutaraldehyde: chitosan-arginine anion resin was 1:14. After Schiff reaction was carried out for 70 min, the resin filter residue was washed 7 times with phosphate buffer saline.
实验结果Experimental results
将实施例1~3制备出的产品,进行了壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶最适催化温度、最适催化pH值、酶活回收率、半衰期试验。试验结果如下:The products prepared in Examples 1-3 were tested for optimum catalytic temperature, optimum catalytic pH value, enzyme activity recovery rate and half-life of chitosan-arginine anion resin immobilized chymotrypsin. The test results are as follows:
从上表可知,壳聚糖-精氨酸阴离子树脂固定化胰凝乳蛋白酶的热稳定性较游离胰凝乳蛋白酶高,固定化胰凝乳蛋白酶最适催化温度为70℃,较游离胰凝乳蛋白酶提高10℃;固定化胰凝乳蛋白酶的最适催化pH值为5.92,较游离胰凝乳蛋白酶降低了2.08,扩大了固定化胰凝乳蛋白酶的使用范围;固定化胰凝乳蛋白酶的活回收率高达到89.95%,75℃的半衰期长达18小时,4℃的半衰期长达56天,提高了固定化胰凝乳蛋白酶的利用效率,降低污染,充分利用资源。It can be seen from the above table that the thermal stability of chitosan-arginine anion resin immobilized chymotrypsin is higher than that of free chymotrypsin, and the optimum catalytic temperature of immobilized chymotrypsin is 70°C, which is higher than that of free chymotrypsin. Lactase increased by 10°C; the optimal catalytic pH value of immobilized chymotrypsin was 5.92, which was 2.08 lower than that of free chymotrypsin, which expanded the application range of immobilized chymotrypsin; The live recovery rate is as high as 89.95%, the half-life at 75°C is as long as 18 hours, and the half-life at 4°C is as long as 56 days, which improves the utilization efficiency of immobilized chymotrypsin, reduces pollution, and makes full use of resources.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100697937A CN101285060B (en) | 2008-06-03 | 2008-06-03 | Process of chitosan-arginine resin anion immobilizing chymotrypsin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100697937A CN101285060B (en) | 2008-06-03 | 2008-06-03 | Process of chitosan-arginine resin anion immobilizing chymotrypsin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101285060A CN101285060A (en) | 2008-10-15 |
CN101285060B true CN101285060B (en) | 2011-09-07 |
Family
ID=40057474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100697937A Expired - Fee Related CN101285060B (en) | 2008-06-03 | 2008-06-03 | Process of chitosan-arginine resin anion immobilizing chymotrypsin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101285060B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8119780B2 (en) | 2006-06-02 | 2012-02-21 | Synedgen, Inc. | Chitosan-derivative compounds and methods of controlling microbial populations |
CN101575384B (en) * | 2009-06-08 | 2011-06-15 | 北京大学 | Nano chitosan derivative and preparation method and application thereof |
CN102174504A (en) * | 2011-01-14 | 2011-09-07 | 华南理工大学 | Granular carrier immobilized lipase for treating papermaking white water and preparation method thereof |
CN102199592B (en) * | 2011-04-02 | 2013-04-03 | 重庆大学 | Method for preparing mixed immobilized glucose oxidase/catalase microspheres |
CN102911928B (en) * | 2012-07-06 | 2014-10-08 | 西南药业股份有限公司 | Immobilized method of creatine kinase |
CN103451255B (en) * | 2013-03-28 | 2016-03-16 | 南京工业大学 | Method for producing hypoxanthine nucleotide |
CN106477557B (en) * | 2016-11-04 | 2018-12-04 | 江南大学 | A kind of carbon nano tube compound material of aromatic aldehyde/chitosan non-covalent modification |
CN107522781A (en) * | 2017-09-01 | 2017-12-29 | 浦江县欧立生物技术有限公司 | The method that collagen peptide is extracted from grass carp scales |
CN109999767A (en) * | 2019-04-17 | 2019-07-12 | 江苏师范大学 | A kind of method of glutaraldehyde modification of chitosan resin adsorption separation purple sweet potato anthocyanin |
-
2008
- 2008-06-03 CN CN2008100697937A patent/CN101285060B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101285060A (en) | 2008-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101285060B (en) | Process of chitosan-arginine resin anion immobilizing chymotrypsin | |
Lv et al. | Immobilization of urease onto cellulose spheres for the selective removal of urea | |
CN102942699B (en) | Self-reinforced bi-crosslinking hyaluronic acid hydrogel and preparation method thereof | |
CN108578764B (en) | A rapid preparation method of bioglass/hydrogel composites | |
CN106188584B (en) | A kind of derivatives of hyaluronic acids hydrogel and preparation method thereof | |
CN106000333B (en) | Preparation method of material for adsorbing lead | |
CN102943069A (en) | Co-immobilization glucose oxidase/catalase microspheres and application thereof in production of gluconic acid or gluconic salt | |
CN105543211A (en) | Immobilized glucose oxidase as well as preparation method and application thereof | |
CN102068965A (en) | Method for preparing chitosan separation medium suitable for protein purification | |
CN101748113B (en) | Method for preparing immobilized glucose isomerase by magnetic chitosan composite microspheres | |
CN106811814A (en) | A kind of cellulose nano-fibrous preparation method and applications of brown alga | |
CN102732500B (en) | Preparation method of oxidized dialdehyde cellulose immobilized urease | |
CN107475226A (en) | A kind of new Bromenzyme and preparation method thereof | |
CN103861566B (en) | A kind of preparation method of efficient adsorption modified starch microspheres and application | |
CN112479301A (en) | Water pollution treatment material of molybdenum disulfide-loaded chitosan microspheres and preparation method thereof | |
CN102504283B (en) | Method for preparing lignosulfonate micro gel | |
CN1687499A (en) | Blended fiber of sodium alginate/water soluble chitin, preparation method and application thereof | |
CN111303491B (en) | Preparation method of bacterial cellulose/polymeric dopamine composite nano material | |
WO2023193429A1 (en) | Method for producing trehalose | |
CN103933937A (en) | Preparation methods and applications of graphene oxide composite and nickel oxide supported graphene composite | |
CN1746193A (en) | A kind of preparation method of low molecular weight chitosan or chitosan oligosaccharide | |
CN107694543A (en) | A kind of method for preparing adsorbent for heavy metal using mao bamboon paper cellulose modification | |
CN113122938A (en) | Preparation method and application of MOFs-containing chitosan/polyvinyl alcohol nanofiber membrane | |
CN114733492A (en) | Microcrystalline cellulose gel adsorbent for adsorbing and separating tetrodotoxin and preparation method thereof | |
CN101942107A (en) | Preparation method of protein-printed polymer of carboxymethyl chitosan and chitosan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110907 Termination date: 20140603 |